Moderna Inc (MRNA)

[axelvento]

We are pleased to share a preprint of the preclinical manuscript for our #vaccine against #SARS-CoV-2 to potentially prevent #COVID19 disease. We thank the NIAID team for their collaboration with our infectious disease research team. https://t.co/weLnGLvfv3 @NIAIDNews

— Moderna (@moderna_tx) June 12, 2020